512 — Grand Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$15.09bn
- HK$19.44bn
- HK$12.28bn
Brief: Grand Pharmaceutical Says Treprostinil Injection For PAH Granted Drug Registration Certificate
Brief: Grand Pharmaceutical Says Sir-Spheres Y-90 Of Associate Co Receives CE Mark Approval
Brief: Grand Pharmaceutical Posts HY Profit Attributable HK$1,169.02 Million
Brief: Grand Pharmaceutical Says Outwit Investments To Buy 224.4 Million Shares Of Co From East Ocean Capital
Brief: Grand Pharmaceutical Says FDA Approved New Indication Of Sir-Spheres Y-90 Resin Microsphere Injection
Brief: Grand Pharmaceutical Says NMPA Accepts Application For Group's RDC TLX591
Brief: Grand Pharmaceutical's Fluticasone Propionate Nasal Spray Approved For Commercialization in China
Brief: Grand Pharmaceutical Posts FY Revenue Of HKD 11,644.89 Mln
Brief: Grand Pharmaceutical Provides Update On Strategic Investment In Telix
Brief: Grand Pharmaceutical Says NDA For Group Treated For Demodex Blepharitis Accepted By Nmpa
Brief: Grand Pharmaceutical Says Novasync Approved By NMPA For Commercialization In China
Brief: Grand Pharmaceutical Obtained Exclusive Development & Commercialization Rights Of Product
Brief: Grand Pharmaceutical Says Phase III Clinical Trial Of GPN00833 Conducted In China
Brief: Grand Pharmaceutical Says First Adjustable Intracranial Stent Retriever Product Produced In China Of Group Approved For Commercialization By NMPA
Brief: Grand Pharmaceutical Says Phase III Clinical Trial Application Of Drug Itm-11 Accepted By NMPA
Brief: Grand Pharmaceutical Says Lam Chit Yee Jessica Appointed As Executive Director
Brief: Grand Pharmaceutical Group Posts H1 Revenue Of HKD6,047.24 Mln
Brief: Grand Pharmaceutical Sees HY Consolidated Net Profit Attributable Increased By Not Less Than 50%
Brief: Grand Pharmaceutical Says Shi Lin Resigned As Executive Director